KR20170028044A - Novel Bacillus amyloliquefaciens CJ 14-6 isolated from the Korean traditional meju and manufacturing method of soybean Koji using this fungi and soybean Koji manufactured therefrom - Google Patents
Novel Bacillus amyloliquefaciens CJ 14-6 isolated from the Korean traditional meju and manufacturing method of soybean Koji using this fungi and soybean Koji manufactured therefrom Download PDFInfo
- Publication number
- KR20170028044A KR20170028044A KR1020150124820A KR20150124820A KR20170028044A KR 20170028044 A KR20170028044 A KR 20170028044A KR 1020150124820 A KR1020150124820 A KR 1020150124820A KR 20150124820 A KR20150124820 A KR 20150124820A KR 20170028044 A KR20170028044 A KR 20170028044A
- Authority
- KR
- South Korea
- Prior art keywords
- soybean
- bacillus amyloliquefaciens
- strain
- isolated
- soybeans
- Prior art date
Links
- 244000068988 Glycine max Species 0.000 title claims abstract description 47
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 47
- 241000193744 Bacillus amyloliquefaciens Species 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title abstract description 28
- 241000233866 Fungi Species 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 13
- 235000013527 bean curd Nutrition 0.000 claims description 29
- 230000000694 effects Effects 0.000 claims description 29
- 108091005804 Peptidases Proteins 0.000 claims description 22
- 239000004365 Protease Substances 0.000 claims description 21
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 21
- 230000003579 anti-obesity Effects 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 7
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 2
- 230000001804 emulsifying effect Effects 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- 238000009331 sowing Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 238000001035 drying Methods 0.000 abstract description 3
- 238000010025 steaming Methods 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 210000001789 adipocyte Anatomy 0.000 description 11
- 150000002632 lipids Chemical class 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 235000013555 soy sauce Nutrition 0.000 description 11
- 210000000577 adipose tissue Anatomy 0.000 description 9
- 230000004069 differentiation Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 240000006439 Aspergillus oryzae Species 0.000 description 6
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 229960005322 streptomycin Drugs 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 210000005228 liver tissue Anatomy 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 235000007862 Capsicum baccatum Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102100023915 Insulin Human genes 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 238000000134 MTT assay Methods 0.000 description 2
- 231100000002 MTT assay Toxicity 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 244000294411 Mirabilis expansa Species 0.000 description 2
- 235000015429 Mirabilis expansa Nutrition 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 239000001728 capsicum frutescens Substances 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 235000018823 dietary intake Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 230000004136 fatty acid synthesis Effects 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 102000010705 glucose-6-phosphate dehydrogenase activity proteins Human genes 0.000 description 2
- 108040005050 glucose-6-phosphate dehydrogenase activity proteins Proteins 0.000 description 2
- 235000009200 high fat diet Nutrition 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 235000013536 miso Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000000528 statistical test Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- 240000005475 Abelmoschus moschatus Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102100033393 Anillin Human genes 0.000 description 1
- 241000228257 Aspergillus sp. Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000011547 Bouin solution Substances 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 108010061189 anillin Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/50—Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
-
- A23L11/09—
-
- A23L11/20—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- C12R1/07—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
Abstract
Description
본 발명은 전통 메주에서 분리한 단백질 분해효소(protease) 활성이 우수하고 항비만 활성을 가지는 신규한 균주인 바실러스 아밀로리쿼페이션스 (Bacillus amyloliquefaciens) CJ 14-6 균주와 이를 이용한 콩곡자(soybean Koji) 제조방법 및 그 제조방법에 의해 제조된 콩곡자에 대한 것이다.The present invention relates to a novel strain, Bacillus amyloliquefaciens CJ 14-6, which has excellent protease activity and has anti-obesity activity, isolated from a traditional meju, and soybean Koji, And a soybean curd produced by the method.
메주는 우리나라의 전통 콩 발효식품인 간장, 고추장 및 된장 등의 원료로 사용되는 발효식품이다. 콩을 주원료로 제조한 메주는 재래식 장류, 즉 간장, 고추장 및 된장 등의 제조를 위한 중요한 스타터(starter)이기도 하다.Meju is a fermented food used as a raw material for traditional soybean fermented foods such as soy sauce, kochujang and miso. Meju, which is mainly made from soybeans, is also an important starter for the production of conventional soy sauce, such as soy sauce, red pepper paste and miso.
메주는 제조방법에 따라 재래식 메주, 개량식 메주 및 산업용 코오지(곡자)로 구분하고 있다. 재래식 메주는 콩만을 이용하여 성형한 후 짚으로 싸서 일정기간 발효시킨 것이고, 개량식 메주는 증자한 콩에 미리 아스퍼질러스속(Aspergillus sp.) 균주로 발효시킨 것이고, 산업적으로 생산되고 있는 코오지는 밀쌀 또는 밀가루를 아스퍼질러스속의 황국균으로 발효시킨 것이다.Meju is classified into conventional meju, improved meju and industrial co-op according to the manufacturing method. Conventional meju is formed by using only soybean, then wrapped in straw and fermented for a certain period of time. The modified meju is fermented with a strain of Aspergillus sp. The wheat flour was fermented by Hwangguk-gyun in Aspergillus.
고추장은 제조방법에 따라 크게 전통식(재래식) 고추장과 공장식(개량식) 고추장으로 나눠진다. 전통식 고추장은 콩과 곡류를 일정한 비율로 섞어 만든 고추장용 메주, 쌀 등의 전분질 원료, 엿기름, 식염 그리고 고춧가루를 섞어 발효 숙성하여 제조된다. 공장식 고추장은 숙성식, 당화식 고추장으로, 고추장용 메주 대신에 아스퍼질러스 오리재(Aspergillus oryzae)를 순수 배양한 코오지를 사용한다. 코오지 제조에는 단백질 원료로서는 콩, 전분질 원료로서는 쌀이나 밀가루가 사용된다.Kochujang is largely divided into traditional (traditional) kochujang and factory (improved) kochujang depending on the manufacturing method. Traditional kochujang is made by mixing fermented soybean meal with soybean paste and red pepper powder, starch raw materials such as meju and rice for kochujang made by mixing soybean and cereal at a certain ratio. The factory-made kochujang is a maturing formula, a saccharified kochujang, and a koji which is a pure culture of Aspergillus oryzae instead of a meju for kochujang. Soy sauce is used as a raw material for protein, and rice or wheat is used as a raw material for starch.
여성의 사회진출이 증가하게 되면서 공장에서 제조한 고추장을 구입하는 가정이 증가하고 있어 이러한 공장식 고추장의 생산량이 계속 증가 추세를 보이고 있으며, 고추장의 수출량 또한 지속적인 증가세를 보이고 있다. As the number of women entering the society increases, the number of households purchasing the kochujang produced at the factory is increasing, and the production of such koshuchang is continuously increasing, and the export amount of kochujang is also continuously increasing.
상기 종래의 공장식 고추장의 대량생산을 위한 방안으로, 대한민국 등록특허 제10-0668056호는 낱알콩에 미리 배양한 미생물을 접종하여 발효시켜 제조하는 콩메주 및 그 제조방법에 관한 것을 개시하고 있다. 보다 상세하게는, 상기 선행기술은 콩을 증자한 후 건조하는 증자단계와 상기 콩에 전통메주로부터 분리하여 배양한 미생물을 접종한 후 일정기간 동안 발효시키는 발효단계를 포함하여 이루어지는 것을 특징으로 하는 콩메주의 제조방법 및 그 방법에 의해 제조된 콩메주를 개시하고 있다.Korean Patent No. 10-0668056 discloses a soybean meju prepared by inoculating microorganisms pre-cultured on a bean bean and fermenting the bean bean as a method for mass production of the conventional plant-based kochujang, and a production method thereof. More specifically, the prior art includes a step of growing soybeans and drying them, and a fermentation step of fermenting the soybeans for a certain period of time after inoculating the microorganisms cultured separately from the traditional meju. And a soybean meju produced by the method.
그러나 상기한 종래 방법에 의하더라도 공장식 고추장의 대량생산을 위한 콩곡자의 개발은 여전히 요구되고 있다.However, even with the above-mentioned conventional methods, there is still a demand for the development of bean curd for mass production of factory-style kochujang.
이에 본 발명자들은 공장식 고추장의 대량생산을 위한 연구의 일환으로서 전통 장류에서 단백질 분해효소 활성이 우수한 균주들을 스크리닝하여 바실러스 아밀로리쿼페이션스 (Bacillus amyloliquefaciens) CJ 14-6 균주를 선별하였고, 이를 이용하여 공장식 고추장의 대량생산에 적합한 콩곡자를 제조할 수 있다는 사실을 확인하여 본 발명을 완성하였다.Accordingly, the present inventors selected strains of Bacillus amyloliquefaciens CJ 14-6 by screening strains having excellent protease activity in a conventional soybean paste as a study for mass production of a plant-based kochujang, It is possible to produce a soybean curd suitable for mass production of a plant-based kochujang, thereby completing the present invention.
따라서, 본 발명의 목적은 전통 메주에서 분리한 균주인 바실러스 아밀로리쿼페이션스 CJ 14-6 균주를 제공하는 것이다.Accordingly, an object of the present invention is to provide a strain of Bacillus amyloliquefaciens CJ 14-6 isolated from a traditional meju.
또한, 본 발명의 다른 목적은 상기 균주를 이용한 콩곡자의 제조방법을 제공하는 것이다.Another object of the present invention is to provide a method for producing soybean curd using the strain.
또한, 본 발명의 또 다른 목적은 상기 제조방법에 의해 제조된 콩곡자를 제공하는 것이다.It is still another object of the present invention to provide a soybean curd produced by the above production method.
상기와 같은 본 발명의 목적을 달성하기 위하여, 본 발명은 전통 메주에서 분리한 단백질 분해효소(protease) 활성이 우수하고 항비만 활성을 가지는 균주인 바실러스 아밀로리쿼페이션스 CJ 14-6 균주를 제공한다.In order to achieve the object of the present invention, the present invention provides a strain of Bacillus amyloliquefaciens CJ 14-6, which is a strain having excellent protease activity and anti-obesity activity isolated from a traditional meju .
본 발명은 또한 콩을 침지 또는 콩에 가수하여 증자시키는 증자 단계; 및 상기 증자된 콩에 바실러스 아밀로리쿼페이션스 CJ 14-6 균주를 접종, 발효시키는 제국 단계를 포함하는 콩곡자의 제조방법을 제공한다.The present invention also relates to a method for producing soybean milk, comprising the steps of: And an empowering step of inoculating and fermenting the Bacillus amyloliquefaciens CJ 14-6 strain to the expanded soybeans.
본 발명은 또한 상기 콩곡자의 제조방법에 의해 제조된 콩곡자를 제공한다.The present invention also provides a bean curd made by the method of manufacturing the bean curd.
본 발명은 단백질 분해효소 활성이 우수한 신규의 균주 바실러스 아밀로리쿼페이션스(Bacillus amyloliquefaciens) CJ 14-6를 전통 메주에서 분리, 선별하고, 이를 콩곡자의 제조에 사용함으로써 공장식 고추장을 대량으로 생산할 수 있게 하는 효과가 있다.The present invention relates to a method for producing a large amount of a plant-type kochujang by separating and selecting a novel strain Bacillus amyloliquefaciens CJ 14-6 having excellent protease activity from a traditional meju and using the same in the production of soybean curd .
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 첫 번째 양태로서, 본 발명은 전통 메주에서 분리한 단백질 분해효소(protease) 활성이 우수한 균주인 바실러스 아밀로리쿼페이션스 CJ 14-6 균주를 제공한다.As a first aspect of the present invention, the present invention provides a strain of Bacillus amyloliquefaciens CJ 14-6, which is a strain having excellent protease activity isolated from a traditional meju.
구체적으로, 본 발명은 우리나라의 전통메주에서 다양한 균주들을 분리한 다음 그 중에서 단백질 분해효소 활성이 탁월한 바실러스 속(Bacillus spp.) 균주를 활성배지에서 1차 선별하고, 2차로 콩을 원료로 고체 배양하여 단백질 분해능력이 강한 균주를 2차 선별하였다. 16s rDNA 염기 서열분석(16s rDNA sequencing)을 통하여 최종 선별된 바실러스 속 균주의 동정을 진행하였다. Specifically, the present invention relates to a method for isolating various strains from Korean traditional meju, followed by first screening of a strain of Bacillus spp., Which has excellent protease activity, from an active medium, and secondly, And the strains having strong proteolytic ability were secondly selected. 16s rDNA sequencing (16s rDNA sequencing) was performed to identify the final selected Bacillus spp.
분리된 바실러스 속 균주는 바실러스 아밀로리쿼페이션스(Bacillus amyloliquefaciens)로 동정되었다(서열번호 1). 단백질 분해효소 활성이 우수한 이 균주를 바실러스 아밀로리쿼페이션스(Bacillus amyloliquefaciens) CJ 14-6으로 명명하고, 이를 2015년 7월 1일에 한국미생물보존센터에 기탁하였다(수탁번호 KCCM11718P).The isolated strain of Bacillus was identified as Bacillus amyloliquefaciens (SEQ ID NO: 1). This strain having excellent protease activity was named Bacillus amyloliquefaciens CJ 14-6 and deposited on July 1, 2015 with the Korean Society for Microbiological Protection (Accession No. KCCM11718P).
본 발명의 두 번째 양태로서, 본 발명은 콩을 침지 또는 콩에 가수하여 증자시키는 증자 단계; 및 상기 증자된 콩에 바실러스 아밀로리쿼페이션스 CJ 14-6 균주를 접종, 발효시키는 제국 단계를 포함하는 콩곡자의 제조방법을 제공한다.According to a second aspect of the present invention, there is provided a method for producing soybean milk, comprising the steps of: And an empowering step of inoculating and fermenting the Bacillus amyloliquefaciens CJ 14-6 strain to the expanded soybeans.
더욱 구체적으로, 본 발명은 콩을 선별 및 세척하고, 콩을 침지 또는 콩에 가수하는 단계; 상기 콩을 증자한 후 냉각시키는 단계; 바실러스 아밀로리쿼페이션스 CJ 14-6을 배양하여 배양액을 제조하는 단계; 및 상기 냉각된 콩에 상기 바실러스 아밀로리쿼페이션스 CJ 14-6 균주의 배양액을 접종, 발효키는 제국 단계를 포함하는 콩곡자의 제조방법을 제공한다.More specifically, the present invention relates to a method for producing soybean milk, comprising the steps of selecting and washing soybean, dipping soybeans or adding soybean to soybeans; Growing the soybeans and cooling them; Culturing Bacillus amyloliquefaciens CJ 14-6 to prepare a culture; And a step of inoculating the cooled soybeans with a culture solution of the strain of Bacillus amyloliquefaciens CJ 14-6, and a step of emulsifying the fermented soybeans.
상기 콩 증자 단계 전, 선별 및 세척된 콩을 침지수의 온도 10℃ 내지 50℃에서 1 내지 15 시간 침지하는 단계를 더 포함하고, 포화 스팀(1.0~2.0 kgf/cm2)을 넣어 100℃ 내지 150℃에서 1 내지 60분간 증자할 수 있으며, 이에 한정되지 않는다. 상기 증자된 콩은 30℃ 내지 50℃ 정도, 더욱 구체적으로 약 30 ~ 35℃ 정도로 냉각시킬 수 있다.Further comprising the step of immersing the soybeans selected and washed before the soybean-growing step at a temperature of 10 to 50 ° C for 1 to 15 hours, and adding saturated steam (1.0 to 2.0 kgf / cm 2 ) 150 ° C for 1 to 60 minutes, but is not limited thereto. The expanded soybeans can be cooled to about 30 캜 to 50 캜, more specifically about 30 to 35 캜.
상기 콩은 고압증기멸균기(Autoclave)로 100℃ 내지 150℃에서 5 내지 15분간 증자할 수 있으며, 더욱 구체적으로, 110℃에서 10분간 증자할 수 있다.The beans can be grown in a high pressure steam sterilizer (autoclave) at 100 ° C to 150 ° C for 5 to 15 minutes, more specifically at 110 ° C for 10 minutes.
상기 바실러스 아밀로리쿼페이션스 CJ 14-6 균주는 포자상태로 전환시켜 배양한 배양액으로 사용할 수 있으며, 상기 배양액은 증자된 콩에 원료 총량 대비 0.1 내지 3.0 중량%로 균일하게 접종할 수 있다.The Bacillus amyloliquefaciens CJ 14-6 strain can be used as a culture solution which is cultured by being transformed into a spore state. The culture solution can be uniformly inoculated into the expanded soy beans at 0.1 to 3.0 wt% based on the total amount of the raw materials.
상기 균주를 배양하는 배양배지는 간장배지일 수 있다. 상기 간장배지는 한식간장, 양조간장 또는 혼합간장으로부터 선택된 간장 1~10% 및 글루코스(glucose), 수크로스(sucrose), 갈락토스(glactose) 또는 말토오스(maltose) 로 이루어진 군으로부터 선택된 당원 0.1 ~ 10%를 혼합하여 제조될 수 있다.The culture medium for culturing the strain may be a soy sauce medium. Wherein the soy sauce medium comprises 1 to 10% of liver selected from Korean soy sauce, brewed soy sauce or mixed soy sauce and 0.1 to 10% of a sugar source selected from the group consisting of glucose, sucrose, glactose or maltose, . ≪ / RTI >
본 발명의 또 다른 실시예에 있어서, 본 발명은 순수 분리하여 보관한 바실러스 아밀로리쿼페이션스 CJ 14-6 균주를 간장배지(양조간장+글루코스)에 접종하고, 30 내지 42℃의 온도범위에서 포자가 생성될 때까지 20 내지 42시간 배양하여 바실러스 아밀로리쿼페이션스 CJ 14-6 균주의 배양액을 제조하였다.In another embodiment of the present invention, the present invention relates to a method for producing Bacillus amyloliquefaciens CJ 14-6 strain inoculated in a soy sauce medium (brewed soy sauce + glucose) Was cultured for 20 to 42 hours to prepare a culture broth of Bacillus amyloliquefaciens CJ 14-6.
바실러스 아밀로리쿼페이션스 CJ 14-6 균주를 접종하여 혼합한 후, 30℃ 내지 45℃, 더욱 구체적으로 34℃ 내지 44℃에서 1 내지 3일간 발효시켜 콩곡자를 제조할 수 있다.Bacillus amyloliquefaciens CJ 14-6 strain is inoculated and mixed, and then fermented at 30 ° C to 45 ° C, more specifically 34 ° C to 44 ° C, for 1 to 3 days to produce soybean curd.
추가적으로, 상기 발효 단계 이후 건조 단계를 진행할 수 있다.In addition, the fermentation step may be followed by a drying step.
본 발명의 세 번째 양태로서, 본 발명은 또한 상기 콩곡자의 제조방법에 의해 제조된 콩곡자를 제공한다.As a third aspect of the present invention, the present invention also provides a bean curd made by the method for manufacturing the bean curd.
본 발명의 제조방법에 의해 제조된 콩곡자는 공장식 고추장의 대량생산에 사용될 수 있다.The soybean curd produced by the production method of the present invention can be used for the mass production of the plant-made kochujang.
이하 본 발명의 내용을 실시예에 의해 보다 상세하게 설명하기로 한다. 다만, 이들 실시예는 본 발명의 내용을 이해하기 위해 제시되는 것일 뿐 본 발명의 권리범위가 이들 실시한 예로 한정되어지는 것으로 해석 되어져서는 아니된다.Hereinafter, the present invention will be described in more detail with reference to Examples. It should be understood, however, that these examples are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art.
[ 실시예 ][Example]
실시예 1 : 전통메주로부터 균주의 분리 및 동정Example 1: Isolation and identification of strains from traditional meju
(1) 균주의 분리 및 동정(1) Isolation and Identification of Strain
본 발명에서 스타터로 사용된 균주는 경기, 강원, 충북, 전남 소재의 전통 식품 제조 업체에서 수거한 전통 메주에서 분리, 선별하였다.The strains used as starters in the present invention were isolated and sorted from traditional meju collected from traditional food manufacturers in Gyeonggi, Gangwon, Chungbuk, and Chonnam.
전통 메주를 멸균수에 희석한 다음, 한천배지(Nutrient agar, Difco)에 도말하여 37℃에서 배양하고, 전통 메주에서 우점종으로 서식하는 세균 5종을 선정하여 순수 분리하여 동정하였다. 분리된 균주를 각각 CJ 3-27, CJ 4-4, CJ 5-10, CJ 14-6 및 CJ 16-57로 명명하였다.Traditional Meju was diluted in sterilized water and then plated on agar medium (Nutrient agar, Difco) and cultured at 37 ℃. Five bacterium species were selected from traditional meju and identified by pure separation. The isolated strains were named CJ 3-27, CJ 4-4, CJ 5-10, CJ 14-6 and CJ 16-57, respectively.
상기 분리된 균주를 영양배지(Nutrient Broth, Difco)에서 37℃, 24시간, 200rpm으로 진탕배양 한 후 프로테아제의 역가를 비교하였다. 동정 결과 및 프로테아제의 역가 결과를 하기 표 1에 나타내었다.The isolated strains were cultured in nutrient broth (Nutrient Broth, Difco) at 37 ° C for 24 hours at 200 rpm, and then the titers of proteases were compared. The results of the identification and the potency of the protease are shown in Table 1 below.
(2) 1차 선별(2) Primary selection
상기 분리, 동정된 균주들 중 가장 낮은 프로테아제 역가를 나타낸 CJ 5-10를 제외한 나머지 균주 CJ 3-27, CJ 4-4, CJ 14-6, 및 CJ 16-57를 1차로 선정하였다.The isolates CJ 3-27, CJ 4-4, CJ 14-6, and CJ 16-57 were selected as the first strains except CJ 5-10, which exhibited the lowest protease activity among the identified strains.
(3) 2차 선별(3) Secondary selection
상기 1차 선별된 균주 4종을 이용하여 콩곡자를 제조하고 각각의 프로테아제 역가를 측정하였다. 그 결과를 하기 표 2에 나타내었으며, 이를 비교하여 우수 균주를 2차 선별하였다.Soybean curds were prepared using the four strains selected first and the protease activity of each strain was measured. The results are shown in Table 2 below, and the excellent strains were secondly selected by comparing them.
콩곡자의 제조를 위해, 콩 1kg을 정수에 12시간 침지한 후 고압증기멸균기 (Autoclave)로 110℃에서 10분간 증자하였으며, 증자 후 35℃로 냉각하였다. 냉각된 증자 콩에 상기 분리된 균주를 원료 총량 대비 2.0 중량%로 혼합한 후 37에서 3일간 각각 배양하였으며, 이를 이용하여 각각 콩곡자를 제조하였다.For the production of soybean curd, 1 kg of soybean was immersed in purified water for 12 hours, and then it was heated at 110 ° C for 10 minutes by autoclave, and after heating, it was cooled to 35 ° C. The separated strains were mixed in the amount of 2.0 wt% based on the total amount of the raw materials, and then cultured at 37 for 3 days, respectively, to prepare soybean curds.
프로테아제 역가 측정은 상기 각각 제조된 콩곡자를 증류수에 30℃에서 1시간 동안 추출, 여과한 것을 조효소액으로 사용하여 수행하였다. 효소 반응액은 조효소액 0.5㎖, 기질로 2% 밀크 카제인(Milk casein) 1.5㎖, Mcllivine 버퍼(pH 6.0) 1㎖를 첨가하여 38℃에서 1시간 반응시켰다. 이후, 0.4M TCA 용액을 3㎖ 넣어 반응을 정지시켜 여과한 후, 0.4M Na2CO3 5㎖와 페놀 시약 1㎖를 넣어 충분히 혼합한 후 38℃에서 30분간 발색시키고, 분광 광도계를 이용하여 660nm에서 흡광도를 측정하였다. 이때, 효소 활성은 1분간 1㎍에 해당하는 티로신을 생성하는 효소의 양을 1 유닛으로 정의하였고, 티로신을 표준 물질로 이용하여 검량선을 작성하였다.Protease activity was measured by extracting each of the soybean curd prepared above with distilled water at 30 ° C for 1 hour and filtering it as a crude enzyme solution. 0.5 ml of crude enzyme solution, 1.5 ml of 2% milk casein and 1 ml of Mcllivine buffer (pH 6.0) were added to the enzyme reaction solution, followed by reaction at 38 ° C for 1 hour. Thereafter, 3 ml of 0.4 M TCA solution was added to stop the reaction. After filtration, 5 ml of 0.4 M Na 2 CO 3 and 1 ml of a phenol reagent were added and mixed thoroughly. The mixture was developed at 38 ° C for 30 minutes, Absorbance was measured at 660 nm. At this time, the enzyme activity was defined as one unit of the amount of enzyme producing tyrosine corresponding to 1 占 퐂 per minute, and a calibration curve was prepared using tyrosine as a standard substance.
상기 표 2의 결과로부터, 프로테아제 역가가 우수한 CJ 3-27과 CJ 14-6 균주를 선정하였다.From the results shown in Table 2, CJ 3-27 and CJ 14-6 strains having excellent protease activity were selected.
(4) 3차 선별 - 시험관 내(In vitro) 3T3-L1 항비만 활성(4) tertiary selection - in vitro 3T3-L1 anti-obesity activity
가.세포주A. Cell line
지방분화세포는 쥐의 배아섬유아세포주(Mouse embry onic fibroblast cell line)인 3T3-L1 세포를 한국세포주은행(KCLB)에서 분양받아 사용하였다.3T3-L1 cells, a mouse embryonic fibroblast cell line, were distributed from Korean Cell Line Bank (KCLB).
나.세포배양B. Cell culture
3T3-L1 세포의 배양은 10% BCS, 1% 페니실린-스트렙토마이신(Penicillin-streptomycin)을 함유하는 DMEM배지를 사용하였다. 세포는 culture dish의 70% 수준으로 증식하였을 때 1,000rpm에서 5분간 원심분리하여 회수하고 1:5의 비율로 계대하여 사용하였다. 3T3-L1 cells were cultured in DMEM medium containing 10% BCS, 1% penicillin-streptomycin. Cells were recovered by centrifugation at 1,000 rpm for 5 minutes when cultured at 70% level in a culture dish.
다.MTTMTT assay assay
MTT assay는 살아있는 세포 내의 미토콘드리아 디하이드로게네이즈(mitochondria dehydrogenase)가 MTT와 반응하여 짙은 푸른색의 MTT 포르마잔 결정(MTT formazan crystal)을 형성하는 것을 기본원리로 하여 Carmichael 등의 방법에 따라 실험하였다. 3T3-L1 세포는 1.5 x 104/ml의 농도로 48웰에 500μl씩 분주 후 세포가 플레이트 바닥에 부착 될 수 있도록 37℃, 5% CO2 인큐베이터에서 24시간 배양했다. 다음날 최종농도 1000, 250, 0 μg/ml이 되도록 각 웰에 시료를 주입하였다. 24시간 배양 후 시료가 포함된 배지에 5 mg/ml로 조정하고 싸이아졸릴 블루 테트라졸리움 브로마이드 용액(Thiazolyl Blue Tetrazolium bromide solution)을 50μl씩 분주하여 최종농도를 500μg/ml로 조정하고 37℃, 5% CO2 인큐베이터에서 4시간 반응시켰다. 반응이 끝나면 MTT 시약이 포함된 배지를 제거하고, DMSO(Dimethyl sulfoxide)를 300μl 가하여 MTT 포르마잔 결정(MTT-formazan crystal)을 용해시키고, 5분 동안 발색을 유도시킨 다음 ELISA microplate reader를 이용하여 540nm에서 흡광도를 측정하였다.The MTT assay was performed according to the method of Carmichael et al. Based on that mitochondria dehydrogenase in living cells reacted with MTT to form a dark blue MTT formazan crystal. 3T3-L1 cells were seeded at a concentration of 1.5 x 10 4 / ml in 500 wells in 48 wells and cultured in a 5% CO 2 incubator at 37 ° C for 24 hours so that the cells could be attached to the plate bottom. The next day, samples were injected into each well to a final concentration of 1000, 250, and 0 μg / ml. After culturing for 24 hours, the medium was adjusted to 5 mg / ml in the medium containing the sample, and 50 μl of thiazolyl blue tetrazolium bromide solution was added thereto. The final concentration was adjusted to 500 μg / ml, % CO 2 incubator for 4 hours. After the reaction was completed, the medium containing the MTT reagent was removed, and 300 μl of DMSO (dimethyl sulfoxide) was added to dissolve the MTT-formazan crystal, followed by induction of color development for 5 minutes. Then, using an ELISA microplate reader, The absorbance was measured.
라.3T3LA3T3 -L1 cell 분화유도-L1 induction of cell differentiation
세포분화를 유도하기 위하여 6웰 플레이트에 세포를 2.5 x 104/ml로 접종하고, 10% FBS와 1% 페니실린-스트렙토마이신(penicillin-streptomycin)을 포함한 DMEM으로 post-confluent 상태가 될 때까지 4일간 37℃, 5% CO2 인큐베이터에서 배양하였다. 항비만 실험에 사용되는 대표적인 양성 컨트롤로는 전지방세포의 분화를 억제, 지방분해 촉진, 성숙한 지방세포의 세포자살을 유도하여 지방형성 억제에 효과가 있는 레스베라톨(resveratol)을 사용하였다. To induce cell differentiation, cells were inoculated at 2.5 x 10 4 / ml in 6-well plates and cultured in DMEM containing 10% FBS and 1% penicillin-streptomycin until a post-confluent state of 4 And cultured in a 5% CO 2 incubator at 37 ° C for a day. Representative positive controls used in anti-obesity experiments include resveratol, which inhibits the differentiation of whole adipocytes, stimulates lipolysis, induces apoptosis of mature adipocytes and inhibits lipogenesis.
Post-confluent상태가 되면 Day 0에 분화유도 배지인 10% FBS, 1% 페니실린-스트렙토마이신(penicillin-streptomycin), 5μg/ml 인슐린, 1μM DMS(dexamethasone), 0.5mM IBMX(3-isobutyl-1-1methylxanthine)를 함유한 배지를 72시간 동안 처리하고 Day 3과 5에는 10%이 FBS, 1% 페니실린-스트렙토마이신(penicillin-streptomycin), 10μg/ml INS만 포함하고 있는 DMEM 분화 진행배지를 처리하였다. 동시에 배지를 교체할 때마다 모든 시료는 최종농도가 10, 50, 0μg/ml이 되도록 처리하였고 양성 컨트롤인 20μg/ml 농도로 처리하였다.In the post-confluent state, Day 0 was supplemented with 10% FBS, 1% penicillin-streptomycin, 5 μg / ml insulin, 1 μM DMS (dexamethasone), 0.5 mM IBMX (3-isobutyl- 1methylxanthine was treated for 72 hours and Day 3 and 5 were treated with DMEM differentiation medium containing 10% FBS, 1% penicillin-streptomycin and 10 μg / ml INS. At the same time, every time the medium was changed, all samples were treated to a final concentration of 10, 50, 0 μg / ml and treated with a positive control, 20 μg / ml.
마.OilE.Oil Red O 염색 및 수치화 Red O dyeing and quantification
배양 중인 3T3-L1 cell의 분화정도를 확인하고자 분화 마지막 날인 7일째에 지방 방울을 염색하는 Oil Red O 시약을 사용하여 Rene 등과 Kasturi 등의 방법을 변형하여 염색하였다.To determine the degree of differentiation of cultured 3T3-L1 cells, Oil Red O reagent, which stains fat droplets on the 7th day of the differentiation, was modified and stained with Rene and Kasturi.
분화가 진행된 세포들은 4% 파라-포름알데히드(para-formaldehyde(in PBS))를 각 웰에 주입하여 상온에서 1시간 이상 반응시켜 고정시켰다. 고정액을 제거하고 0.5% Oil Red O staining으로 1시간 동안 세포를 염색하였고, 남은 염색을 제거하기 위해 흐르는 물에 2회 세척하여 염색시약이 플레이트에 남아있지 않도록 하였으며, 염색된 방울은 이소프로판올에 용해하여 510nm에서 흡광도를 측정하였다. The differentiated cells were fixed with 4% para-formaldehyde (in PBS) at room temperature for 1 hour or more. Cells were stained with 0.5% Oil Red O staining for 1 hour and washed twice in running water to remove remaining staining to ensure that the staining reagent did not remain on the plate. Dyed droplets were dissolved in isopropanol Absorbance was measured at 510 nm.
프로테아제 활성이 높은것으로 확인된 2종의 바실러스 아밀로리쿼페이션스 (Bacillus amyloliquefaciens) CJ 3-27, CJ 14-6의 지방세포분화 억제능을 비교하여 In vitro 항비만 활성을 측정하였다. In vitro anti - obesity activity was measured by comparing the inhibitory effect of two kinds of Bacillus amyloliquefaciens CJ 3-27 and CJ 14-6, which were confirmed to have high protease activity, on adipocyte differentiation.
(μg /ml) Concentration of culture medium
(Μ g / ml)
(%)(%)
CJ 3-27Bacillus amyloliquefaciens
CJ 3-27
CJ 14-6Bacillus amyloliquefaciens
CJ 14-6
통계학적 검정 : student-T testStatistical tests: Student-T test
* : P < 0.05*: P < 0.05
상기 표3의 결과가 나타내는 바와 같이, 지방세포 분화억제율에서 유의적 변화가 없는 CJ 3-27 균주배양액에 비해 CJ14-6 균주배양액의 지방세포 분화억제율은 유의적 수준의 저해를 나타내었다.As shown in the above Table 3, inhibition rate of adipocyte differentiation of CJ14-6 culture medium was significantly inhibited compared to that of CJ 3-27 culture medium in which the inhibition rate of adipocyte differentiation was not significantly changed.
실시예Example 2 : 2 : 콩곡자의Bean 제조 Produce
상기 실시예 1에서 최종 선별된 신규의 균주인 바실러스 아밀로리쿼페이션스(Bacillus amyloliquefaciens) CJ 14-6를 종균으로 이용하여 상기 실시예 1-(1)에 기재된 콩곡자 제조방법에 따라 콩곡자를 제조하였다.A soybean curd was prepared according to the soybean curd production method described in Example 1- (1) above using the newly selected strain, Bacillus amyloliquefaciens CJ 14-6, finally selected in Example 1 as a seed strain . Respectively.
기존의 아스퍼질러스 오리재를 이용한 콩곡자와의 비교를 위하여, 충무발효에서 시판되는 통상의 아스퍼질러스 오리재(Aspergillus oryzae)를 국균(麴菌)으로 이용하여 상기 실시예 1-(1)에 기재된 콩곡자 제조방법에 따라 콩곡자를 제조하였다.For comparison with soybean curd using conventional Aspergillus oryzae , in Example 1- (1), Aspergillus oryzae commercially available from Chungmu fermentation was used as Aspergillus , The soybean curd was prepared according to the soybean curd production method described in "
(1) 프로테아제 역가 측정(1) Protease activity measurement
상기 각각의 콩곡자의 프로테아제 역가를 측정하였으며, 그 결과를 하기 표 4에 나타내었다.The protease activity of each soybean curd was measured and the results are shown in Table 4 below.
상기 표 4의 결과로부터, 신규의 바실러스 아밀로리쿼페이션스 (Bacillus amyloliquefaciens) CJ 14-6 균주를 적용한 콩곡자의 프로테아제 효소 역가가 통상의 아스퍼질러스 오리재(Aspergillus oryzae)를 적용한 콩곡자보다 120.6%가 향상되어 고추장 또는 된장에서 사용시 단백질 성분의 분해력을 촉진하여 맛품질을 향상하는데 기여할 수 있다.From the results in Table 4, it was found that the protease enzyme activity of the bean curd using the novel strain of Bacillus amyloliquefaciens CJ 14-6 was 120.6% higher than that of the bean curd using Aspergillus oryzae , Can improve the decomposition ability of the protein component when used in the koji paste or doenjang to improve the taste quality.
실험예 1 : 신균주(CJ14-6) 적용 콩곡자에 의한 항비만 효능 측정Experimental Example 1: Application of new strain (CJ14-6)
신규의 아밀로리퀴페이션스 (Bacillus amyloliquefaciens) CJ 14-6 콩곡자(실시예 4)에 의한 항비만 효능 검증을 위하여 동물실험을 수행하였다. 실험에 이용한 동물은 수컷 흰쥐(S.D. rat 5주령)로 다물사이언스(대한민국)에서 구입하여 사용하였고, 사육실 온도는 18±2℃로 유지하며 조명은 12시간 주기(08:00~20:00)로 조절하였다.Animal experiments were conducted to verify the anti-obesity efficacy of the new Bacillus amyloliquefaciens CJ 14-6 soybean curd (Example 4). The animals used in the experiment were purchased from Darussian (Korea) with male rats (5-week-old SD rats), maintained at 18 ± 2 ℃ and illuminated 12 hours (08: 00 ~ 20: 00) Respectively.
실험쥐들은 7마리씩 2개의 군으로 나누어, 대조군에는 흰쥐용 분말사료에 돼지기름(lard) 20%를 첨가하여 고지방식이를 급여하였고, 실시예2군에는 상기 고지방식이에 본 발명의 신균주 적용 콩곡자 분말을 0.91% 급여하였다. 이들에 대한 체중 및 지방조직 무게는 표 5 및 6에 나타내었다.Experimental rats were divided into two groups of 7 rats. In the control group, 20% of lard (lard) was added to the rat powder feed, and the high fat diet was fed. In the high fat diet group, Application Soybean curd powder was fed 0.91%. Weight and fat tissue weights for these are shown in Tables 5 and 6.
체중과 식이섭취량은 1주일마다 측정하였고, 지방조직 무게 및 지질함량은 시험종료 전 12시간절식 시킨 후 측정하였다. 채취한 혈액은 1,900xG에서 20분간 원심분리 시킨 후 혈정을 분리하여 혈청 지질함량 시료로 사용하였다. 간과 지방조직의 총 지질, 중성지방 및 총 콜레스테롤 함량 분석을 위하여 적출한 간과 지방조직 0.1g에 클로로폼-메탄올(chloroform-methanol)(2:1, v/v)을 첨가하여 냉장상태에서 3일간 방치한 후 증류수를 첨가하고, 1,150xG에서 20분간 원심분리 시킨 후 지질층인 하층부의 총 지질 함량을 측정하였다. 이 총 지질을 희석하여 총 콜레스테롤과 중성지방 함량 분석을 위하여 사용하였다. 이를 통한 혈청 및 조직의 지질함량결과는 표 7, 8, 9 및 10에 나타내었다.Body weight and dietary intake were measured every week, and fat tissue weight and lipid content were measured after fasting for 12 hours before the end of the test. The collected blood was centrifuged at 1,900 × G for 20 minutes, and the serum was separated and used as a serum lipid content sample. To analyze the total lipid, triglyceride and total cholesterol content of hepatic and adipose tissues, 0.1 g of liver and adipose tissues were added with chloroform-methanol (2: 1, v / v) After left standing, distilled water was added and the total lipid content in the lower layer of the lipid layer was measured after centrifugation at 1,150 x G for 20 minutes. This total lipid was diluted and used for the analysis of total cholesterol and triglyceride content. The results of lipid content of serum and tissues are shown in Tables 7, 8, 9 and 10.
지방조직의 지방산 생합성 관련 효소 활성 측정을 위하여 지방조직 무게의 3배 부피에 해당하는 0.1M 인산칼륨 버퍼(potassium phosphate buffer)(pH 7.4, 37℃)를 첨가하여 균질화 한 후, 3,000rpm 에서 15분간 원심분리하고 상층액을 다시 15,000rpm에서 30분간 원심분리한 다음, 상층액 만을 모아 사용하였다. 이를 통한 효소활성 결과는 표11 및 12에 나타내었다.To measure the fatty acid biosynthesis-related enzymatic activity of adipose tissue, 0.1M potassium phosphate buffer (pH 7.4, 37 ° C) corresponding to 3 times the weight of adipose tissue was added and homogenized. The resulting solution was incubated at 3,000 rpm for 15 minutes After centrifugation, the supernatant was again centrifuged at 15,000 rpm for 30 minutes, and then the supernatant was collected. The results of enzyme activity are shown in Tables 11 and 12.
지방세포의 크기 측정을 위하여 적출한 지방조직에 부앙용액(Bouin solution)으로 고정하여 파라핀 블록을 제작하여 절편 슬라이드를 제작한 후 아닐린 블루(Anillin blue) 염색액을 사용하여 염색하였다. 이후 전자현미경을 통해 지방세포의 사진을 찍은 후 처리구간의 지방세포를 비교하였다.For the measurement of adipocyte size, paraffin blocks were prepared by fixing the adipose tissue with a Bouin solution, and slides were prepared and stained with anillin blue staining solution. After the photograph of the adipocyte was taken through the electron microscope, the adipocytes in the treatment zone were compared.
통계학적 검정 : student-T testStatistical tests: Student-T test
* : P < 0.05*: P < 0.05
** : P < 0.01**: P < 0.01
*** : P < 0.001***: P < 0.001
상기 표5의 결과가 나타내는 바와 같이, 실시예2군의 체중증가율은 대조군에 비해 91.5% 수준임을 확인할 수 있었다. 또한, 표6의 결과 신장주위 지방조직 무게에서도 대조군에 비해 83.3%로 그 무게 증가량이 감소하였다.As shown in the results of Table 5, it was confirmed that the weight gain of the group of Example 2 was 91.5% higher than that of the control group. In addition, as shown in Table 6, the weight gain of peripheral fat tissue was reduced to 83.3% as compared with the control.
따라서 상기 실시예의 결과로부터 신균주(CJ14-6) 적용 콩곡자가 체중감량효과가 있음을 알 수 있다.Therefore, it can be seen from the results of the above example that the soybean strain of the new strain (CJ14-6) has a weight loss effect.
<110> CJ Cheiljedang Corporation <120> Novel Bacillus amyloliquefaciense CJ 14-6 isolated from the Korean traditional meju and manufacturing method of soybean Koji using this fungi and soybean Koji manufactured therefrom <130> PA14-0407 <160> 1 <170> KoPatentIn 3.0 <210> 1 <211> 1418 <212> DNA <213> Bacillus amyloliquefaciens <400> 1 agtcgagcgg acagatggga gcttgctccc tgatgttagc ggcggacggg tgagtaacac 60 gtgggtaacc tgcctgtaag actgggataa ctccgggaaa ccggggctaa taccggatgg 120 ttgtttgaac cgcatggttc agacataaaa ggtggcttcg gctaccactt acagatggac 180 ccgcggcgca ttagctagtt ggtgaggtaa cggctcacca aggcgacgat gcgtagccga 240 cctgagaggg tgatcggcca cactgggact gagacacggc ccagactcct acgggaggca 300 gcagtaggga atcttccgca atggacgaaa gtctgacgga gcaacgccgc gtgagtgatg 360 aaggttttcg gatcgtaaag ctctgttgtt agggaagaac aagtgccgtt caaatagggc 420 ggcaccttga cggtacctaa ccagaaagcc acggctaact acgtgccagc agccgcggta 480 atacgtaggt ggcaagcgtt gtccggaatt attgggcgta aagggctcgc aggcggtttc 540 ttaagtctga tgtgaaagcc cccggctcaa ccggggaggg tcattggaaa ctggggaact 600 tgagtgcaga agaggagagt gggagtacca cgtgtagcgg tgacatgcgt agagatgtgg 660 aggaacacca gtggcgaagg cgactctctg gtctgtaact gacgctgagg agcgacagcg 720 tggggagcga acaggattag ataccctggt agtccacgcc gtaaacgatg agtgataagt 780 gttagggggt ttccgccctt tagtgctgca gctaacgcat taagcactcc gcctggggag 840 tacggtcgca agagtgaaac tcaaaggaat tgacgggggc ccgcacaagc ggtggagcat 900 gtggtttaat tagaagcaac gcgaagaacc ttaccaggtc ttgacatcct ctgacaatcc 960 tagagatagg acgtcccctt cgggggcaga gtgacaggtg gagcatggtt gtcgtcagct 1020 cgtgtcgtga gatgttgggt taagtcccgc aacgagcgca acccttgatt ttagttgcca 1080 gcattcagtt gggcactcta aggtgactgc cggtgacaaa ccggaggaag gtggggatga 1140 cgtcaaatca tcatgcccct tatgacctgg gttacacacg tgttacaatg gacagaacaa 1200 agggcagcga aaccgcgagg ttaagccaat cccacaaatc tgttttcagt tcggatcgca 1260 gtctgcaact cgactgcgtg aagctggaat cgctagtaat cgcggatcag catgccgcgg 1320 tgaatacgtt cccgggcctt gtacacaccg cccgtctctc cacgagagtt tgtaacaccc 1380 gaagtcggtg aggtaacctt ttaggagcca gccgccga 1418 <110> CJ Cheiljedang Corporation <120> Novel Bacillus amyloliquefaciense CJ 14-6 isolated from the Korean traditional meju and manufacturing method of soybean Koji using this fungi and soybean Koji prepared therefrom <130> PA14-0407 <160> 1 <170> KoPatentin 3.0 <210> 1 <211> 1418 <212> DNA <213> Bacillus amyloliquefaciens <400> 1 agtcgagcgg acagatggga gcttgctccc tgatgttagc ggcggacggg tgagtaacac 60 gtgggtaacc tgcctgtaag actgggataa ctccgggaaa ccggggctaa taccggatgg 120 ttgtttgaac cgcatggttc agacataaaa ggtggcttcg gctaccactt acagatggac 180 ccgcggcgca ttagctagtt ggtgaggtaa cggctcacca aggcgacgat gcgtagccga 240 cctgagaggg tgatcggcca cactgggact gagacacggc ccagactcct acgggaggca 300 gcagtaggga atcttccgca atggacgaaa gtctgacgga gcaacgccgc gtgagtgatg 360 aaggttttcg gatcgtaaag ctctgttgtt agggaagaac aagtgccgtt caaatagggc 420 ggcaccttga cggtacctaa ccagaaagcc acggctaact acgtgccagc agccgcggta 480 atacgtaggt ggcaagcgtt gtccggaatt attgggcgta aagggctcgc aggcggtttc 540 ttaagtctga tgtgaaagcc cccggctcaa ccggggaggg tcattggaaa ctggggaact 600 tgagtgcaga agaggagagt gggagtacca cgtgtagcgg tgacatgcgt agagatgtgg 660 aggaacacca gtggcgaagg cgactctctg gtctgtaact gacgctgagg agcgacagcg 720 tggggagcga acaggattag ataccctggt agtccacgcc gtaaacgatg agtgataagt 780 gttagggggt ttccgccctt tagtgctgca gctaacgcat taagcactcc gcctggggag 840 tacggtcgca agagtgaaac tcaaaggaat tgacgggggc ccgcacaagc ggtggagcat 900 gtggtttaat tagaagcaac gcgaagaacc ttaccaggtc ttgacatcct ctgacaatcc 960 tagagatagg acgtcccctt cgggggcaga gtgacaggtg gagcatggtt gtcgtcagct 1020 cgtgtcgtga gatgttgggt taagtcccgc aacgagcgca acccttgatt ttagttgcca 1080 gcattcagtt gggcactcta aggtgactgc cggtgacaaa ccggaggaag gtggggatga 1140 cgtcaaatca tcatgcccct tatgacctgg gttacacacg tgttacaatg gacagaacaa 1200 agggcagcga aaccgcgagg ttaagccaat cccacaaatc tgttttcagt tcggatcgca 1260 gtctgcaact cgactgcgtg aagctggaat cgctagtaat cgcggatcag catgccgcgg 1320 tgaatacgtt cccgggcctt gtacacaccg cccgtctctc cacgagagtt tgtaacaccc 1380 gaagtcggtg aggtaacctt ttaggagcca gccgccga 1418
Claims (7)
상기 증자된 콩에 제1항의 바실러스 아밀로리쿼페이션스 CJ 14-6 균주를 접종, 발효시키는 제국 단계
를 포함하는 콩곡자의 제조방법.A step of growing soybeans by immersion or sowing on soybeans; And
The emulsifying step of inoculating and fermenting the thus-grown soybean with the Bacillus amyloliquefaciens strain CJ 14-6 of claim 1
≪ / RTI >
상기 증자 단계 전, 선별 및 세척된 콩을 10 내지 50℃에서 1 내지 15시간 침지하는 단계를 더 포함하고,
상기 증자 단계는, 1.0 내지 2.0 kgf/cm2의 포화 스팀을 넣어 100℃ 내지 150℃에서 1 내지 60분간 증자하는 단계를 포함하는 것을 특징으로 하되,
상기 증자 단계 후, 상기 증자된 콩을 30 내지 50℃로 냉각하는 단계를 더 포함하는 것을 특징으로 하는 콩곡자의 제조방법.3. The method of claim 2,
Further comprising the step of immersing the selected soybeans at 10 to 50 < 0 > C for 1 to 15 hours before the growing step,
The boiling step includes the step of adding saturated steam of 1.0 to 2.0 kgf / cm 2 at 100 ° C to 150 ° C for 1 to 60 minutes,
Further comprising a step of cooling the soybeans to 30 to 50 < 0 > C after the increasing step.
상기 증자 단계는 고압증기멸균기(Autoclave)로 100℃ 내지 150℃에서 5 내지 15분간 수행하는 것을 특징으로 하는 콩곡자의 제조방법.3. The method of claim 2,
Wherein the growing step is carried out in a high pressure steam sterilizer (Autoclave) at 100 ° C to 150 ° C for 5 to 15 minutes.
상기 바실러스 아밀로리쿼페이션스 CJ 14-6 균주는 상기 증자된 콩에 원료 총량 대비 0.1 내지 3.0 중량%가 되도록 접종하는 것을 특징으로 하는 콩곡자의 제조방법.3. The method of claim 2,
Wherein the Bacillus amyloliquefaciens CJ 14-6 strain is inoculated to the beans so that the amount of the added beans is 0.1 to 3.0 wt% based on the total amount of the raw materials.
A soybean curd having an anti-obesity activity produced by the method according to any one of claims 2 to 5.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150124820A KR101745784B1 (en) | 2015-09-03 | 2015-09-03 | Novel Bacillus amyloliquefaciens CJ 14-6 isolated from the Korean traditional meju and manufacturing method of soybean Koji using this fungi and soybean Koji manufactured therefrom |
RU2018111322A RU2694943C1 (en) | 2015-09-03 | 2016-09-01 | New strain isolated from traditional mejo, soy koji preparation method using this strain and soy koji prepared by such method |
US15/757,097 US10645962B2 (en) | 2015-09-03 | 2016-09-01 | Strain isolated from traditional meju, soybean koji preparation method using same, and soybean koji prepared by the same preparation method |
CN201680051376.2A CN107922916B (en) | 2015-09-03 | 2016-09-01 | Novel strain separated from traditional soy sauce koji, bean koji making method using the same, and bean koji made by the making method |
PCT/KR2016/009804 WO2017039361A1 (en) | 2015-09-03 | 2016-09-01 | New strain isolated from traditional meju, soybean koji preparation method using same, and soybean koji prepared by same preparation method |
JP2018511708A JP6484391B2 (en) | 2015-09-03 | 2016-09-01 | A new strain isolated from traditional miso balls, a method for producing bean paste using the same, and a bean paste produced by the method |
EP16842327.5A EP3345993B1 (en) | 2015-09-03 | 2016-09-01 | New strain isolated from traditional meju, soybean koji preparation method using same, and soybean koji prepared by same preparation method |
US16/843,201 US11700871B2 (en) | 2015-09-03 | 2020-04-08 | Strain isolated from traditional meju, soybean koji preparation method using same, and soybean koji prepared by the same preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150124820A KR101745784B1 (en) | 2015-09-03 | 2015-09-03 | Novel Bacillus amyloliquefaciens CJ 14-6 isolated from the Korean traditional meju and manufacturing method of soybean Koji using this fungi and soybean Koji manufactured therefrom |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170028044A true KR20170028044A (en) | 2017-03-13 |
KR101745784B1 KR101745784B1 (en) | 2017-06-20 |
Family
ID=58187961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150124820A KR101745784B1 (en) | 2015-09-03 | 2015-09-03 | Novel Bacillus amyloliquefaciens CJ 14-6 isolated from the Korean traditional meju and manufacturing method of soybean Koji using this fungi and soybean Koji manufactured therefrom |
Country Status (7)
Country | Link |
---|---|
US (2) | US10645962B2 (en) |
EP (1) | EP3345993B1 (en) |
JP (1) | JP6484391B2 (en) |
KR (1) | KR101745784B1 (en) |
CN (1) | CN107922916B (en) |
RU (1) | RU2694943C1 (en) |
WO (1) | WO2017039361A1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100668056B1 (en) | 2005-05-17 | 2007-01-11 | 김필준 | Soybean malt and manufacturing method thereby |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA971031A (en) * | 1972-12-11 | 1975-07-15 | Tadanobu Nakadai | Process for manufacturing soy sauce using enzymatic preparation(s) |
JPS6283861A (en) * | 1985-10-09 | 1987-04-17 | Bell Shokuhin Kk | Delicious soybean malt free from ill odor |
CA2614457A1 (en) * | 2005-07-22 | 2007-01-25 | Asahi Breweries, Ltd. | Method of producing liquid koji |
JP2008222701A (en) * | 2007-03-09 | 2008-09-25 | Kangwon National Univ Industry Cooperation Foundation | Fermented product for preventing and treating obesity, fermented product for preventing diabetes, fermented food for preventing and treating obesity and food for preventing diabetes |
JP5904522B2 (en) * | 2011-03-17 | 2016-04-13 | 国立大学法人東北大学 | Microorganisms producing azasugar |
KR20130033026A (en) * | 2011-09-26 | 2013-04-03 | 전북대학교산학협력단 | Novel bacillus amyloliquefaciens by04 having high protease producing activity and process for producing protease using the same |
KR101458556B1 (en) * | 2012-01-20 | 2014-11-05 | 부산대학교 산학협력단 | Fermentation products of probiotic mixed cultures and functional health foods, medicinal composition including the same |
US9199191B2 (en) * | 2012-08-17 | 2015-12-01 | Ube Industries, Ltd. | Gas separation membrane module and method of replacing a hollow fiber element |
KR101474301B1 (en) * | 2012-10-15 | 2014-12-18 | 한국식품연구원 | Bacillus amyloliquefaciens 140N producing 1-Deoxynojirimycin and method for producing fermented soybean having anti-diabetic activity using thereof |
KR101518106B1 (en) * | 2012-10-31 | 2015-05-07 | 씨제이제일제당 (주) | Manufacturing method of the korea traditional meju-deonjang by using a novel strains, bacillus amyloliquefaciens cj 3-27 and aspergillus oryzae cj kg |
KR20140072338A (en) * | 2012-11-30 | 2014-06-13 | 씨제이제일제당 (주) | Manufacturing Methods of Korean traditional Fermented Soybeans |
KR20140069999A (en) * | 2012-11-30 | 2014-06-10 | 씨제이제일제당 (주) | Manufacturing method of the Korean traditional Meju |
KR20140123847A (en) * | 2013-04-15 | 2014-10-23 | 재단법인 발효미생물산업진흥원 | Bacillus amyloliquefaciens AGI-63 strain having alpha-glucosidase inhibitor activity isolated from traditionally fermented soybean product and uses thereof |
KR102128737B1 (en) * | 2014-01-27 | 2020-07-01 | 경희대학교 산학협력단 | Strains with functionality isolated from Doenjang, method for preparation of functional Doenjang using the same and fuctional Doenjang prepared by using said method |
KR101740583B1 (en) * | 2014-02-17 | 2017-05-29 | 경희대학교 산학협력단 | Novel lactic acid bacteria having anti-obesity effect and use thereof |
CN104694424B (en) * | 2015-02-12 | 2017-12-01 | 江西师范大学 | One plant of Bacillus amyloliquefaciens strain for being isolated from producing protease in fermented soya bean |
CN104877936A (en) * | 2015-05-15 | 2015-09-02 | 江西师范大学 | Fibrinolytic-enzyme-producing Bacillus amyloliquefaciens strain separated from traditional fermented black beans |
-
2015
- 2015-09-03 KR KR1020150124820A patent/KR101745784B1/en active IP Right Grant
-
2016
- 2016-09-01 WO PCT/KR2016/009804 patent/WO2017039361A1/en active Application Filing
- 2016-09-01 JP JP2018511708A patent/JP6484391B2/en active Active
- 2016-09-01 EP EP16842327.5A patent/EP3345993B1/en active Active
- 2016-09-01 CN CN201680051376.2A patent/CN107922916B/en active Active
- 2016-09-01 RU RU2018111322A patent/RU2694943C1/en active
- 2016-09-01 US US15/757,097 patent/US10645962B2/en active Active
-
2020
- 2020-04-08 US US16/843,201 patent/US11700871B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100668056B1 (en) | 2005-05-17 | 2007-01-11 | 김필준 | Soybean malt and manufacturing method thereby |
Also Published As
Publication number | Publication date |
---|---|
US20200253250A1 (en) | 2020-08-13 |
RU2694943C1 (en) | 2019-07-18 |
KR101745784B1 (en) | 2017-06-20 |
CN107922916A (en) | 2018-04-17 |
US10645962B2 (en) | 2020-05-12 |
JP6484391B2 (en) | 2019-03-13 |
US20180242619A1 (en) | 2018-08-30 |
EP3345993A1 (en) | 2018-07-11 |
WO2017039361A1 (en) | 2017-03-09 |
EP3345993B1 (en) | 2020-12-09 |
CN107922916B (en) | 2021-05-18 |
EP3345993A4 (en) | 2019-03-06 |
US11700871B2 (en) | 2023-07-18 |
JP2018526008A (en) | 2018-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sarkar et al. | Bacillus fermentation of soybeans | |
KR101518106B1 (en) | Manufacturing method of the korea traditional meju-deonjang by using a novel strains, bacillus amyloliquefaciens cj 3-27 and aspergillus oryzae cj kg | |
JP6612973B2 (en) | Method for producing chili miso with rice and chili miso with rice produced by the production method | |
WO2015080514A1 (en) | Method for preparing gochujang and gochujang prepared by preparation method | |
KR102065584B1 (en) | Method for producing tomato fermented liquid with enhanced antioxidant and anti-obesity activity using Lactobacillus plantarum SRCM102223 strain | |
JP6853624B2 (en) | New plant-derived lactic acid bacteria | |
KR101745784B1 (en) | Novel Bacillus amyloliquefaciens CJ 14-6 isolated from the Korean traditional meju and manufacturing method of soybean Koji using this fungi and soybean Koji manufactured therefrom | |
KR101228552B1 (en) | Food material comprising garlic and manufacturing method thereof | |
KR101773335B1 (en) | Method for producing Chunggukjang with increased quality and preference and Chunggukjang produced by the same method | |
KR102353394B1 (en) | Methods for preparing oat doenjang using a novel Bacillus subtilis TSD | |
KR20160079388A (en) | Korean Traditional Meju Prepared by Modified Process and Manufacturing Method of Doenjang and Soy Sauce Using the Same | |
KR100927573B1 (en) | A method of preparing seed cell for natto using Bacillus subtilis BN-NUC1(KCCM-10839P) | |
KR20160047117A (en) | Process for preparing functional vinegar using soybean mejoo | |
KR100661707B1 (en) | DJI Method for preparing reduced off-flavor Doenjangsoybean paste composed of 100% soybean using Bacillus subtilis DJI | |
KR101719780B1 (en) | Novel Penicillium polonicum M and use therof | |
KR102497827B1 (en) | Lactiplantibacillus plantarum DCF49 new strain derived from shindari and production method of functional postbiotics using the same | |
KR100607157B1 (en) | Method for producing pepper paste and pepper paste prepared therefrom | |
KR101280538B1 (en) | A novel Lactic Acid producing Bacteria from Korean Traditional Meju and use thereof | |
KR20060061788A (en) | Microorganisms for producing pepper paste | |
KR100926252B1 (en) | Method for Preparing Fermented Soybeans Using Rotative Fermentation in Liquefied Form | |
KR20210011224A (en) | Nodaji-Cheonggukjang improved anti-oxidant effect and preparation method of the same | |
KR20060061787A (en) | Microorgamisms for producing pepper paste | |
KR20090081610A (en) | Producing Method for Natto using Roasted Bean and the Natto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20200225 Year of fee payment: 4 |